Advanced company searchLink opens in new window

SPUR THERAPEUTICS LIMITED

Company number 09500073

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
01 Apr 2021 SH10 Particulars of variation of rights attached to shares
01 Apr 2021 SH02 Consolidation of shares on 25 February 2021
01 Apr 2021 SH08 Change of share class name or designation
24 Mar 2021 RP04AP01 Second filing for the appointment of Stephen Patrick Diamond Jr as a director
18 Mar 2021 PSC05 Change of details for Freeline Therapeutics Holdings Limited as a person with significant control on 15 July 2020
15 Mar 2021 MA Memorandum and Articles of Association
15 Mar 2021 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
15 Mar 2021 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
09 Mar 2021 AP01 Appointment of Brian Silver as a director on 18 February 2021
09 Mar 2021 AP01 Appointment of Stephen Patrick, Jr Diamond as a director on 18 February 2021
  • ANNOTATION Second Filing a second filed AP01 was registered on 24.03.2021.
09 Mar 2021 AP01 Appointment of Benjamin Charles George Warriner as a director on 18 February 2021
09 Mar 2021 TM02 Termination of appointment of Olswang Cosec Limited as a secretary on 18 February 2021
08 Mar 2021 TM01 Termination of appointment of Jeffrey Allan Chodakewitz as a director on 18 February 2021
08 Mar 2021 TM01 Termination of appointment of Julia Paige Gregory as a director on 18 February 2021
08 Mar 2021 TM01 Termination of appointment of Martin Andrews as a director on 18 February 2021
08 Mar 2021 TM01 Termination of appointment of Christopher Hollowood as a director on 18 February 2021
08 Mar 2021 TM01 Termination of appointment of Amit Chunilal Nathwani as a director on 18 February 2021
07 Jan 2021 PSC02 Notification of Freeline Therapeutics Holdings Limited as a person with significant control on 27 June 2020
07 Jan 2021 PSC07 Cessation of Syncona Limited as a person with significant control on 27 June 2020
29 Dec 2020 AP01 Appointment of Mrs Theresa Marie Heggie as a director on 4 June 2020
02 Oct 2020 AA Group of companies' accounts made up to 31 December 2019
22 Jul 2020 SH08 Change of share class name or designation
22 Jul 2020 SH08 Change of share class name or designation
22 Jul 2020 SH08 Change of share class name or designation
22 Jul 2020 SH08 Change of share class name or designation